- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT01848938
Treatment of Stress Urinary Incontinence Via Smartphone
Descripción general del estudio
Estado
Condiciones
Intervención / Tratamiento
Descripción detallada
Female urinary incontinence (UI) is very common and affects up to one fourth of grownup women. It may reduce quality of life for those affected and costs for society are high. The most common type of urinary incontinence is SUI, i.e leakage when coughing, sneezing or jumping.
The recommended first line treatment is pelvic floor muscle training (PFMT)which leads to improvement or cure in two-thirds of patients. In addition, life style changes, such as weight loss when obese, smoking cessation and reduction of fluid intake if high is recommended.
There is a need for new , flexible and easily accessible treatment programmes for female urinary incontinence. In our previous study, we compared two treatment programmes for SUI without face-to-face contact: one internet based and one sent by post, both based on three months of PFMT. In this randomized controlled trial of 250 women aged 18-70 years, we found highly significant improvements (p<0.001) with large effect sizes (>0,8)concerning primary outcomes (symptoms and quality of life scores) but no significant differences between groups. Compared with the postal group, more participants in the internet group perceived they were much or very much improved (40.9% vs 26.5%, p<0.01, reported reduced usage of incontinence aids (59.5% vs 41.4%, p=0.02) and were satisfied with the treatment programme (84.8% vs 62.9%, p<0.001).
The selling of smartphones is increasing rapidly. About 75% of all cellphones sold in Sweden today are smartphones. Two million adults in Sweden have a smartphone. Many smartphone owners have at least one health app on their phone. Exercise, diet, and weight apps are the most popular types.
From our previous experience of an Internet-based programme, we have developed a treatment program designed for smartphone. The effect of the treatment programme will be evaluated after three months by comparing the effect in the "smartphone group" with the effect in the "waiting group".
Participants are consecutively recruited through our website. They answer an online screening survey with automated immediated response for initial screening of eligibility criteria. Informed consent and leakage diary (number of episodes of urinary leakage during 48 hours) are sent by post. After that, they answer a web questionnaire and finally they are interviewed by a researcher to confirm the diagnosis SUI and to ascertain that the patient is well informed of the study procedure.
Women are then randomized to either of the two groups. Women in the smartphone group get a smartphone application for iphone or android. Follow-up after three months with a web questionnaire and a leakage diary. After that the waiting group get their smartphone application.
We aim to recruit 120 women aged 18 and older via our website www.tät.nu. In the power calculation we assume that the improvement in the symptom score (ICIQ UI SF) and the QOL score (ICIQ luts QOL)in the smartphone group will be similar to the improvement we found in the postal group in our previous study. We also assume that the waiting group will improve in some extent.
To detect a difference between groups, power 80%, 2-side test and significance 0,05, group size as follow
ICIQ UI SF Smartphone group improves 2.9 (SD3,1) and waiting group 1,0 (SD2,0); 30 in each group
ICIQ luts QOL Smartphone group improves 4.6 (SD6,7) and waiting group 2.0(SD3.0), 35 in each group
PGI (patient´s global impression of improvement). 26,5% improves much or very much (smartphone) and 4% (waiting group):39 in each group
We expect a drop out rate of 33% and thus need approximately 120 persons, 60 in each group.
Tipo de estudio
Inscripción (Actual)
Fase
- No aplica
Contactos y Ubicaciones
Ubicaciones de estudio
-
-
-
Umeå, Suecia, S-90185
- Umeå University
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Descripción
Inclusion Criteria:
- stress urinary incontinence
- leakage once a week or more often
- duration of symptoms for at least 6 months
- motivation and time to perform a 12 week long treatment with pelvic floor muscle training
- ability to read and write Swedish
- asset to smartphone
- possibility to send and receive email and asset to printer
- accept to be randomized to one of two groups; a treatment group or a waiting list group
Exclusion Criteria:
- participation in our previous internet study
- pregnancy
- former incontinence surgery
- known malignancy in lower abdomen
- difficulties with passing urine
- visual blood in urine
- intermenstrual bleeding
- severe psychiatric diagnosis
- neurological disease with affection on sensibility in legs or lower abdomen
- urge incontinence
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Tratamiento
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Ninguno (etiqueta abierta)
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Comparador activo: Smartphone treatment
Smartphone treatment with PFMT.
|
A smartphone application with information on SUI, life style information, different programmes of PFMT with increasing severity, possibility to save statistics on training.
The treatment period is three months
|
|
Sin intervención: Waiting list
Waiting list for three months.
They receive the smartphone application after follow-up.
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
International Consultation on Incontinence Modular Questionnaire Urinary Incontinence Short Form (ICIQ-UI SF)
Periodo de tiempo: baseline, three months
|
Three items on frequency, amount of leakage and overall impact.
Scoring 0-21, higher values indicating increasing severity
|
baseline, three months
|
|
International Consultation on Incontinence Modular Questionnaire Lower Urinary Tract Symptoms Quality of Life (ICIQ-LUTSqol)
Periodo de tiempo: baseline, three months
|
The instrument includes 19 items on the impact of the leakage.
All items are scored 1-4 (not at all/never, slightly/sometimes, moderately/often, a lot/all the time).
The overall score is 19-76, with higher values indicating increased impact on QOL.
|
baseline, three months
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Usage of Incontinence Aids
Periodo de tiempo: three months
|
Usage of incontinence aids during the last 4 weeks.
|
three months
|
|
Patient Satisfaction
Periodo de tiempo: three months
|
A self-rated question about if the current treatment was sufficient, with three response options
|
three months
|
|
Incontinence Episode Frequency (IEF)
Periodo de tiempo: baseline, three months
|
number of incontinence episodes per week
|
baseline, three months
|
|
Patient's Global Impression of Improvement Scale (PGI-I)
Periodo de tiempo: three months
|
A self-rated question that asks about the change experienced after treatment with 7 response options, ranging from "very much better" to "very much worse".
|
three months
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Silla de estudio: Eva Samuelsson, MD, PhD, Department of Public Health and Clinical Medicine, Umeå University
Publicaciones y enlaces útiles
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio
Finalización primaria (Actual)
Finalización del estudio (Actual)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Estimar)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- VisareNorr301811
- JLL314561 (Otro número de subvención/financiamiento: The County council of Jämtland)
- FAS2008-0952 (Otro número de subvención/financiamiento: Swedish Council for Working Life and Social research)
- ALFVLL222081 (Otro número de subvención/financiamiento: Västerbotten County Council (ALF))
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .